Award-winning medtech firm, Glyconics© has secured £1.5million in an Enterprise Investment Scheme (EIS) funding round ahead of a series A round next year. The innovative diagnostics startup, with offices in Cambridge, Norwich and Basingstoke, raised well over the intended £850k in a raise led by investment platform Wealth Club and existing investors, Deepbridge Capital and Boundary Capital. Demand from Wealth Club private investors and angel investors pushed the total amount further to £1.5 million.